PeptidesInfo

Research area

Skin and hair

Skin research is one of the few areas with human trials of non-approved peptides, mostly small, short and industry-supported: topical GHK-Cu for photoaged skin and oral collagen peptides for hydration and elasticity. Hair-growth claims for peptides, including GHK-Cu, are supported by animal and in-vitro data but not by adequate human trials.

Abstract illustration of a peptide chain used as the skin and hair research hub image

Evidence map: peptides studied in this area

How grades work →
PeptideEvidence for this areaRegulatory statusWhat has been studied
Collagen peptidesPromising evidenceNot FDA-approvedMultiple randomised placebo-controlled trials and meta-analyses report modest improvements in skin hydration and elasticity after 8–12 weeks of oral supplementation; most are industry-funded.
GHK-CuPreliminary evidenceNot FDA-approvedSmall human trials of topical copper peptide creams report improvements in fine lines, elasticity and photodamage versus placebo or vehicle; hair-growth evidence is animal/cell only.

Grades reflect the strength of evidence for this research area specifically. Definitions: Established, Promising, Preliminary, Preclinical, Unsupported, Conflicting.

Skin: small trials, real but modest effects

Cosmetic endpoints — hydration, elasticity, wrinkle depth by imaging — are relatively easy to measure and cheap to study, so skin has more human data than most peptide areas. Two caveats apply to almost all of it: trials are short (8–16 weeks) and small (often under 100 participants), and most are funded by the company selling the ingredient. That does not make the results wrong, but it does mean we grade skin evidence no higher than promising until independent replication exists.

  • Oral collagen peptides: several randomised placebo-controlled trials and pooled analyses report statistically significant improvements in skin hydration and elasticity. Effects are modest and the clinical meaningfulness of a few percent change in elastometry is debated.
  • Topical GHK-Cu: small trials of copper peptide creams report improvements in photoaged skin. Formulations, concentrations and comparators vary widely, and independent replication is thin.

Hair: mostly animal and cell data

GHK-Cu is often marketed for hair growth. The supporting studies are largely in-vitro (dermal papilla cells) and animal, plus mechanistic reasoning by analogy to minoxidil. We are not aware of an adequately powered randomised human trial of a copper peptide for hair loss with a validated hair-count endpoint. Until one exists this claim stays preclinical on the GHK-Cu profile.

Comparison to approved options

For hair loss, minoxidil and finasteride have FDA approval and decades of trial data. For photoaging, topical retinoids are the evidence benchmark. Peptide claims should be read against those benchmarks, not against "doing nothing".

Analyses in skin and hair

Benefits4 min read

Peptides for Hair Growth: What Has Actually Been Tested

Copper peptides and biotinoyl tripeptide-1 are sold widely for hair loss. The supporting studies are mostly cells and animals. Here is what exists in humans, and how it compares with the two treatments that have decades of trial data.

Benefits4 min read

Copper Peptides vs Retinoids: Comparing the Skin Evidence

Copper peptides and topical retinoids are both sold for photoaged skin. One has several small trials, the other decades of large ones. What each has actually demonstrated, and the head-to-head trial nobody has run.

Benefits4 min read

Are Peptides Worth It? A Framework for Deciding

Whether a peptide is worth it depends on four things: what benefit is proven, in whom, for how long, and whether the effect lasts after you stop. Here is that framework applied to every peptide we cover.

Benefits4 min read

Peptides for Skin: The Benefits With Human Trials Behind Them

Skin is one of the few areas where peptides have real human trials. Topical copper peptides and oral collagen both improve measurable skin properties — modestly, over weeks, in studies mostly funded by the people selling them.

Benefits8 min read

Peptide Benefits: What the Evidence Actually Supports

Peptides are credited with dozens of benefits. Some are proven in large trials, some are modest and real, and some have never been tested in a person. This is every major benefit claim, sorted by how strong the human evidence is.

Benefits4 min read

Collagen Peptide Benefits: What to Expect, and When

Collagen peptides have more randomised human trials than any other supplement peptide. The benefits are real, small, and take 8–24 weeks to appear. Here is what each one is worth in measurable terms.

Research analysis4 min read

GHK-Cu: Skin, Hair, Wound Healing, and Evidence Quality

Copper peptide GHK-Cu has decades of laboratory work, small human trials for topical skin use, and a growing injectable market with no human data. We grade each claim — skin, hair, wounds, 'gene resetting' — separately.

Research analysis4 min read

Collagen Peptides: Joint, Skin, and Recovery Evidence

Oral collagen peptides are the rare non-drug peptide product with multiple randomised trials. The effects on skin hydration, activity-related joint pain and (with training) lean mass are real but small, and most trials are industry-funded. Here is what the studies show and where the gaps are.